Loading company…
Nucleus RadioPharma develops radiopharmaceutical manufacturing and supply capabilities for cancer treatments.
Founded in 2022 by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma develops technologies for radiopharmaceutical clinical development, manufacturing, and supply. In April 2026, it raised USD 50 million in venture funding from OrbiMed Advisors. The company planned to expand manufacturing capacity at its Rochester facility and begin building a second site outside Philadelphia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in